Ankyrin repeat domain 11 (ANKRD11), also called ANCO-1, is located within the 16q24.3 breast cancer loss of heterozygosity (LOH) region [9] and was a p53 coactivator in breast cancer [10], implying a putative tumour-suppressor role. This evidence concerns the gene ANKRD11 and breast carcinoma.